Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 25, 2015	Sep. 26, 2014
Current assets:
Cash and cash equivalents	$ 531,926	$ 568,472
Restricted cash	2,936	2,142
Short-term investments	138,901	231,208
Accounts receivable, net of allowance for doubtful accounts of $1,615 and $514	101,563	86,168
Inventories	13,872	8,536
Deferred taxes	97,101	86,445
Prepaid expenses and other current assets	32,031	22,880
Total current assets	918,330	1,005,851
Long-term investments	321,015	296,335
Property, plant and equipment, net	403,091	289,755
Intangible assets, net	127,507	63,700
Goodwill	307,708	277,574
Deferred taxes	46,178	41,746
Other non-current assets	9,464	9,051
Total assets	2,133,293	1,984,012
Current liabilities:
Accounts payable	20,710	15,898
Accrued liabilities	169,307	158,376
Income taxes payable	754	2,600
Deferred revenue	18,910	12,496
Total current liabilities	209,681	189,370
Long-term deferred revenue	30,581	19,279
Other non-current liabilities	77,024	43,715
Total liabilities	317,286	252,364
Stockholders' equity:
Additional paid-in capital	17,571	46,415
Retained earnings	1,800,857	1,660,485
Accumulated other comprehensive income	(11,462)	3,014
Total stockholders’ equity – Dolby Laboratories, Inc.	1,807,068	1,710,017
Controlling interest	8,939	21,631
Total stockholders’ equity	1,816,007	1,731,648
Total liabilities and stockholders’ equity	2,133,293	1,984,012
Class A Common Stock [Member]
Stockholders' equity:
Common stock	51	51
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 51	$ 52